ARTICLE
28 February 2025

Holland & Knight Health Dose: February 25, 2025

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting...
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Executive Order Updates
  • The White House Announces Request for Information (RFI) on Artificial Intelligence (AI)
  • HHS Rescinds Previous Administration's Guidance from the Office of Civil Rights (OCR)
  • Secretary Kennedy Plans to Revamp HHS Advisory Committees
  • Potential Tariffs on Pharmaceutical Products by April 2, 2025
  • Personnel Updates
  • Reconciliation
  • Retirements
  • FDA Quietly Rehires Previously Fired Employees
  • CMS Announces Public Engagement Events for the Second Cycle of Negotiations
  • FDA Update on Semaglutide Shortage

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More